TrialGynecologic oncology2009

A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers.

Divya Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.